Portfolio company
Synerkine Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops fusion protein therapeutics to treat chronic pain and peripheral neuropathy for patients with inflammatory and neurodegenerative conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Mimetic Medicines
This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
Hoba Therapeutics ApS
This biotech company develops therapeutic proteins to treat patients suffering from chronic neuropathic pain and sensorineural hearing loss.
Nervonik
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems for patients suffering from chronic neuropathic pain.
Dolinnov
This biotechnology company develops non-opioid RNA therapies for patients suffering from severe chronic pain, including cancer and neuropathic conditions.
Neurosciences
This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.
Synergia
The company develops optoelectronic neuromodulation devices for patients requiring vagus nerve stimulation and magnetic resonance imaging compatibility.
Hoba Therapeutics
This biotech company develops therapeutic proteins and non-opioid compounds to treat patients suffering from chronic neuropathic pain and sensorineural hearing loss.